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Background: ICDs are effective for the prevention of sudden death due to ventricular arrhythmias (VT/VF). However, nearly 10-15% of ICD 
recipients receive inappropriate therapies. Controversy exists regarding the significance of such therapies. This study compared the frequency of 
inappropriate device therapy between men and women enrolled in MADIT II and MADIT-CRT, and assessed whether such therapies were associated 
with increased mortality.
Methods: The electrograms for each ICD or CRT-D therapy (i.e. antitachycardia pacing or shock), were reviewed by adjudication committees for 
both studies. ICD therapy was considered inappropriate if it was delivered for reasons other than VT/VF. The rhythm triggering inappropriate therapy 
was categorized as atrial fibrillation, SVT or inappropriate sensing when possible.
Results: 1776 men and 503 women received cardiac ICD or CRT-D devices. The risk of inappropriate device therapy was significantly lower in 
women than men (HR 0.68 [95% CI 0.49-0.93]; p=0.018) by multivariate analysis. Although the risk of inappropriate therapy due to SVT was similar, 
women were at lower risk due to a lower frequency of atrial fibrillation. Inappropriate therapy was not associated with increased mortality in either 
women (HR 1.08 [95% CI 0.25-4.66]; p=0.9) or men (HR 1.05 [95% CI 0.58-1.93]); p=0.87). Conversely, appropriate shock therapy correlated 
strongly with increased risk of death during subsequent post-shock follow-up in women (HR 6.14 [95%CI 2.57-14.64]; p=<0.0001) and men (HR 
3.26 95% CI 2.13-4.99]; p<0.0001).
Conclusions: Women experience significantly less inappropriate device therapies than men, partially explained by an increased frequency of atrial 
fibrillation in men. Inappropriate device therapy was not associated with increased mortality in either gender. Appropriate shock therapy was a strong 
predictor of death, with women showing a nearly two-fold higher risk than men during post-shock long-term follow-up.
